Management of Menopausal Symptoms for Women Who Are at High Risk of Thrombosis.

Published

Journal Article (Review)

For women at elevated risk of thrombosis, clinicians are challenged to relieve menopausal symptoms without increasing the risk of thrombosis. Oral menopausal hormone therapy increases the risk of venous thromboembolism by 2-fold to 3-fold. Observational studies suggest less thrombotic risk with transdermal therapies and with progesterone over synthetic progestogens (progestins), but the data are limited. Beneficial nonpharmacologic therapies include cognitive behavioral therapy and clinical hypnosis, whereas beneficial nonhormonal pharmacologic therapies include selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors. For treatment of the genitourinary syndrome of menopause, vaginal lubricants and moisturizers, low-dose vaginal estrogen, and intravaginal dehydroepiandrosterone are options.

Full Text

Duke Authors

Cited Authors

  • Pinkerton, JV; James, AH

Published Date

  • June 2018

Published In

Volume / Issue

  • 61 / 2

Start / End Page

  • 260 - 268

PubMed ID

  • 29419532

Pubmed Central ID

  • 29419532

Electronic International Standard Serial Number (EISSN)

  • 1532-5520

Digital Object Identifier (DOI)

  • 10.1097/GRF.0000000000000358

Language

  • eng

Conference Location

  • United States